Jiangxi Sanxin MedtecLtd 관리

관리 기준 확인 4/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Zhiping Mao

최고 경영자

CN¥713.8k

총 보상

CEO 급여 비율	n/a
CEO 임기	13.9yrs
CEO 소유권	0.4%
경영진 평균 재임 기간	3.7yrs
이사회 평균 재임 기간	4.9yrs

최근 관리 업데이트

Recent updates

Investors Shouldn't Be Too Comfortable With Jiangxi Sanxin MedtecLtd's (SZSE:300453) Earnings

Oct 21

Jiangxi Sanxin Medtec Co.,Ltd.'s (SZSE:300453) Price Is Right But Growth Is Lacking After Shares Rocket 37%

Oct 08

Returns Are Gaining Momentum At Jiangxi Sanxin MedtecLtd (SZSE:300453)

Sep 30

Jiangxi Sanxin MedtecLtd (SZSE:300453) Is Due To Pay A Dividend Of CN¥0.15

Apr 23

Jiangxi Sanxin Medtec Co.,Ltd.'s (SZSE:300453) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Apr 04

Concerns Surrounding Jiangxi Sanxin MedtecLtd's (SZSE:300453) Performance

Mar 29

CEO

Zhiping Mao (50 yo)

13.9yrs

테뉴어

CN¥713,800

보상

Mr. Zhiping Mao is General Manager of Jiangxi Sanxin Medtec Co.,Ltd. since December 26, 2010 and served as its Deputy General Manager.

리더십 팀

이름	위치	테뉴어	보상	소유권
Zhiping Mao	GM & Non-Independent Director	no data	CN¥713.80k	0.41% CN¥ 16.7m
Zhenrong Le	Deputy GM & Non-Independent Director	no data	CN¥679.90k	0.23% CN¥ 9.4m
Lingli Leng	Vice President	2.7yrs	CN¥664.90k	0.032% CN¥ 1.3m
Ming Liu	VP, Board Secretary & Non-Independent Director	no data	CN¥679.90k	0.057% CN¥ 2.3m
Ling Peng	Vice President	8.9yrs	CN¥679.90k	0.064% CN¥ 2.6m
Ganying Wang	Vice President	3.7yrs	CN¥679.90k	0.10% CN¥ 4.3m

3.7yrs

평균 재임 기간

43yo

평균 연령

경험이 풍부한 관리: 300453 의 관리팀은 경험 ( 3.7 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Zhiping Mao	GM & Non-Independent Director	13.9yrs	CN¥713.80k	0.41% CN¥ 16.7m
Zhenrong Le	Deputy GM & Non-Independent Director	1.8yrs	CN¥679.90k	0.23% CN¥ 9.4m
Ming Liu	VP, Board Secretary & Non-Independent Director	4.9yrs	CN¥679.90k	0.057% CN¥ 2.3m
Fenglian Lei	Vice Chairman	13.9yrs	CN¥713.80k	5.2% CN¥ 213.3m
Guofeng Chen	Independent Director	1.6yrs	CN¥45.50k	데이터 없음
Yixing Peng	Non-Independent Chairman	13.9yrs	CN¥793.10k	29.79% CN¥ 1.2b
Zhenzhu Yu	Chairman of the Board of Supervisors	8.9yrs	데이터 없음	데이터 없음
Haihong Jiang	Independent Director	4.9yrs	CN¥78.00k	데이터 없음
Lin Zhang	Non-Employee Supervisor	7.9yrs	데이터 없음	0.062% CN¥ 2.5m
Meihua Zeng	Supervisor	4.3yrs	데이터 없음	데이터 없음
Xiaohua Xia	Independent Director	1.6yrs	CN¥45.50k	데이터 없음

4.9yrs

평균 재임 기간

49yo

평균 연령

경험이 풍부한 이사회: 300453 의 이사회는 경험(평균 재직 기간 4.9 년)으로 간주됩니다.

Jiangxi Sanxin MedtecLtd 관리

관리 기준 확인 4/4

주요 정보

최근 관리 업데이트

Jiangxi Sanxin Medtec Co.,Ltd., Annual General Meeting, Apr 16, 2024

Insufficient new directors

High number of new directors

Recent updates

Investors Shouldn't Be Too Comfortable With Jiangxi Sanxin MedtecLtd's (SZSE:300453) Earnings

Third quarter 2024 earnings released: EPS: CN¥0.12 (vs CN¥0.10 in 3Q 2023)

Jiangxi Sanxin Medtec Co.,Ltd.'s (SZSE:300453) Price Is Right But Growth Is Lacking After Shares Rocket 37%

Jiangxi Sanxin Medtec Co.,Ltd. to Report Q3, 2024 Results on Oct 15, 2024

Investor sentiment improves as stock rises 24%

Returns Are Gaining Momentum At Jiangxi Sanxin MedtecLtd (SZSE:300453)

Jiangxi Sanxin Medtec Co.,Ltd. Announces Interim Profit Distribution Plan to Be Implemented on A Shares for the Year 2024, Payable on 09 September 2024

Second quarter 2024 earnings released: EPS: CN¥0.10 (vs CN¥0.087 in 2Q 2023)

Jiangxi Sanxin Medtec Co.,Ltd. to Report First Half, 2024 Results on Jul 26, 2024

Now 23% undervalued

Jiangxi Sanxin MedtecLtd (SZSE:300453) Is Due To Pay A Dividend Of CN¥0.15

Dividend of CN¥0.15 announced

Jiangxi Sanxin Medtec Co.,Ltd.'s (SZSE:300453) Price Is Right But Growth Is Lacking After Shares Rocket 27%

Jiangxi Sanxin Medtec Co.,Ltd. to Report Q1, 2024 Results on Apr 17, 2024

Concerns Surrounding Jiangxi Sanxin MedtecLtd's (SZSE:300453) Performance

Full year 2023 earnings released: EPS: CN¥0.40 (vs CN¥0.36 in FY 2022)

Jiangxi Sanxin Medtec Co.,Ltd., Annual General Meeting, Apr 16, 2024

Jiangxi Sanxin Medtec Co.,Ltd. (SZSE:300453) announces an Equity Buyback for CNY 60 million worth of its shares.

Investor sentiment deteriorates as stock falls 19%

Jiangxi Sanxin Medtec Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 23, 2024

Third quarter 2023 earnings released: EPS: CN¥0.10 (vs CN¥0.074 in 3Q 2022)

Jiangxi Sanxin Medtec Co.,Ltd. to Report Q3, 2023 Results on Oct 21, 2023

Second quarter 2023 earnings released: EPS: CN¥0.087 (vs CN¥0.11 in 2Q 2022)

Jiangxi Sanxin Medtec Co.,Ltd. to Report First Half, 2023 Results on Aug 05, 2023

First quarter 2023 earnings released: EPS: CN¥0.11 (vs CN¥0.093 in 1Q 2022)

Now 21% undervalued

Full year 2022 earnings released: EPS: CN¥0.47 (vs CN¥0.40 in FY 2021)

Insufficient new directors

Third quarter 2022 earnings released: EPS: CN¥0.096 (vs CN¥0.11 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.094 in 2Q 2021)

Jiangxi Sanxin Medtec Co.,Ltd. Announces Final Cash Dividend for 2021, Payable on 29 April 2022

High number of new directors

Jiangxi Sanxin Medtec Co.,Ltd. Announces Cash Dividend for 2021

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.095 in 3Q 2020)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: EPS CN¥0.094 (vs CN¥0.076 in 2Q 2020)

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.05 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.24 in FY 2019)

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS CN¥0.45 (vs CN¥0.24 in FY 2019)

New 90-day high: CN¥18.61

Jiangxi Sanxin Medtec Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 27, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

New 90-day low: CN¥15.92

Third quarter earnings released

Jiangxi Sanxin Medtec Co.,Ltd. to Report Q3, 2020 Results on Oct 19, 2020

New 90-day low - CN¥17.05

Earnings released

New 90-day high - CN¥24.73

Jiangxi Sanxin Medtec Co.,Ltd. to Report First Half, 2020 Results on Aug 19, 2020

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령